Leukemia Triple Combination Therapy for CLL: Acalabrutinib, Obinutuzumab and Chlorambucil Apr 17, 2023
Leukemia Magrolimab-Azacitidine Combo vs. Venetoclax-Azacitidine: A Study for TP53 Mutant AML Mar 30, 2023
Leukemia Acalabrutinib vs Investigator's Choice in Relapsed/Refractory CLL: ASCEND Trial Mar 30, 2023
Leukemia Evaluating Idasanutlin in Relapsed or Refractory AML: The MIRROS Clinical Trial Mar 30, 2023
Leukemia Sequoia: A Comparison of Zanubrutinib vs. Bendamustine Plus Rituximab for CLL/SLL Mar 30, 2023
Head & Neck Cancer KEYNOTE-040: Clinical Trial of Pembrolizumab for Head and Neck Cancer Mar 30, 2023
